Turning Point Stock Doubles on Bristol Deal. What It Means for Biotech M&A.

Text size Photograph by Georges Gobet/AFP/Getty Images Turning Point Therapeutics stock has more than doubled after Bristol Myers Squibb announced that it had agreed to buy the company. It’s just the ...